Scientists track tiny radioactive dose to map Drug's journey
NCT ID NCT07423286
Summary
This study aimed to understand how a new Pfizer drug candidate, PF-07248144, is absorbed and processed by the body. Eight healthy adult volunteers received the drug both by mouth and by IV, with a tiny, safe radioactive marker to help track it. Researchers collected blood, urine, and stool samples to measure exactly how much drug entered the bloodstream and how the body eliminated it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit - Madison
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.